The company has 435 technical staff, including 86 new product developers, all of whom have a bachelor's degree or above, 14 of whom have a graduate degree or above, and 36 have senior professional titles. In terms of hardware, it is not only equipped with complete ultraviolet, infrared, liquid phase, gas phase and other analytical instruments, but also has a complete set of equipment required for the three-level R&D platform of small test, pilot test and scale-up production, especially for solid preparation small test, pilot test, Large-scale production is equipped with high-speed granulators, one-step granulators, high-speed tablet presses, high-efficiency coating pots and other solid preparation equipment, and the freeze-dried product research and development platform is equipped with small freeze dryers. Scale-up production can directly utilize internationally advanced solid preparation production lines and injection production lines. In recent years, a large amount of investment in R&D funds has paid off, and 57 new products of various types have been developed, including 8 Class II new drugs, 26 Class IV new drugs, and 23 Class V new drugs, including Ouyi, Weihong, Kangwei New varieties, including Su, Gubang, Xuanning, Oulaining and other products, have been fully launched into the market and achieved good economic benefits.
Ouyi, Weihong, Gubang and other brands have developed into well-known domestic brands, and Ouyi has been recognized as a well-known trademark in China. A number of traditional Chinese medicine varieties such as Qingrejiedu soft capsules have obtained national traditional Chinese medicine protection. Xuanning, Weihong, Gubang and other varieties have a number of national patents.